The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,339K data for 617K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.EBI
Kurukshetra University
Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H.EBI
Kurukshetra University
Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.EBI
University Of Ljubljana
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.EBI
University Of Florida
Identification of 3-acetyl-2-aminoquinolin-4-one as a novel, nonpeptidic scaffold for specific calpain inhibitory activity.EBI
Ewha Womans University
Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.EBI
Merck Research Laboratories
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.EBI
Merck Frosst Centre For Therapeutic Research
Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C.EBI
Merck Frosst Canada
Substrate optimization for monitoring cathepsin C activity in live cells.EBI
Genomics Institute Of The Novartis Research Foundation
Bicyclic carbamates as inhibitors of papain-like cathepsin proteases.EBI
The Genomics Institute Of The Novartis Research Foundation
Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors.EBI
Arpida
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?EBI
Glaxosmithkline
Acyclic cyanamide-based inhibitors of cathepsin K.EBI
Glaxosmithkline
A structural screening approach to ketoamide-based inhibitors of cathepsin K.EBI
Glaxosmithkline
Novel and potent cyclic cyanamide-based cathepsin K inhibitors.EBI
Glaxosmithkline
Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.EBI
Glaxosmithkline
New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.EBI
Albert-Ludwigs-University Of Freiburg